Roni Mamluk - May 16, 2022 Form 4 Insider Report for Ayala Pharmaceuticals, Inc. (AYLA)

Role
President & CEO, Director
Signature
/s/ Roni Mamluk, Ph.D.
Stock symbol
AYLA
Transactions as of
May 16, 2022
Transactions value $
$0
Form type
4
Date filed
5/16/2022, 04:10 PM
Previous filing
Jan 5, 2022
Next filing
Jan 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AYLA Common Stock Award $0 +120K +82.56% $0.00 265K May 16, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted common stock, which will vest quarterly over a period of three years from May 16, 2022.